Title : Phenotypic Parameters in Genotypically Selected Type 2B von Willebrand Disease Patients: A Large, Single-Center Experience Including a New Novel Mutation.

Pub. Date : 2017 Feb

PMID : 27978591






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 von Willebrand disease type 2B (VWD2B) expresses gain-of-function mutations that enhance binding of an individual"s von Willebrand factor (VWF) to its platelet ligand, glycoprotein Ib (GPIb), and which are usually identified by increased ristocetin-induced platelet aggregation (RIPA). Ristocetin von Willebrand factor Homo sapiens
2 von Willebrand disease type 2B (VWD2B) expresses gain-of-function mutations that enhance binding of an individual"s von Willebrand factor (VWF) to its platelet ligand, glycoprotein Ib (GPIb), and which are usually identified by increased ristocetin-induced platelet aggregation (RIPA). Ristocetin von Willebrand factor Homo sapiens